✨ Free AI Report
Kuros Biosciences AG: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Kuros Biosciences AG
Company Research

Kuros Biosciences AG: Business Overview, Financials & Competitive Analysis

Kuros Biosciences AG scores 6/10 on the AskCyborg Cyborg Score (Solid). Kuros offers focused orthobiologic innovation in the large spinal fusion market, supported by clinical validation and emerging commercialization, though execution risk remains on Fibrin-PTH advancement. Kuros demonstrates solid commercialization progress with MagnetOs generating meaningful adoption, strong IP portfolio with 20+ granted patents, and clinical advancement of promising pipeline candidates.

What is Kuros Biosciences AG's industry? Kuros Biosciences AG (kurosbio.com) operates in Orthobiologics/Medical Devices - Spinal Fusion. AskCyborg classifies Kuros Biosciences AG under Orthobiologics/Medical Devices - Spinal Fusion in its company registry.

Kuros Biosciences is a Swiss biotech company developing innovative orthobiologic products focused on spinal fusion and bone regeneration. The company's lead commercial product, MagnetOs, is a synthetic bone graft with...

6/ 10Solid

Cyborg Score thesis

Kuros offers focused orthobiologic innovation in the large spinal fusion market, supported by clinical validation and emerging...

Read the full analyst-debate transcript →
Industry Orthobiologics/Medical Devices - Spinal Fusion
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Kuros Biosciences AG Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Kuros Biosciences AG

AskCyborg analysts argue the bull and bear cases for Kuros Biosciences AG across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Kuros Biosciences AG OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Kuros Biosciences AG Overview

Pro stress-test →

Kuros Biosciences is a Swiss biotech company developing innovative orthobiologic products focused on spinal fusion and bone regeneration. The company's lead commercial product, MagnetOs, is a synthetic bone graft with advanced submicron surface technology that has been used in over 10,000 spinal fusion surgeries across three continents. Kuros addresses a significant clinical need in managing spine-related pain and non-union complications.

Strategic Profile

Pro stress-test →

Kuros positions itself as a next-generation leader in orthobiologics with proprietary patent-protected bone graft technologies and a drug-biologic pipeline. The company has built distribution agreements across Europe and the US, with operations in Switzerland, Netherlands, and Massachusetts. Its strategic competitive advantage lies in its MagnetOs osteoinductive technology and advancement of Fibrin-PTH, the first drug-biologic combination for interbody spinal fusions.

Competitive Landscape

Pro stress-test →

Kuros competes in orthobiologics against larger medical device companies including Medtronic, NuVasive, Zimmer Biomet, and smaller biotech firms. The company's differentiation is based on proprietary submicron surface technology and novel drug-biologic combinations. The spinal fusion market is highly competitive but large ($3B+ annual opportunity), with Kuros focused on premium MagnetOs positioning and Fibrin-PTH's first-mover advantage in drug-biologic combinations.

Industry Context

Kuros Biosciences AG operates in Orthobiologics/Medical Devices - Spinal Fusion.

Key facts

Founded: 2016 · Headquarters: Schlieren, Switzerland · Employees: 66

What the analysts stress-tested

The top findings that survived the multi-agent debate for Kuros Biosciences AG.

  • MagnetOs commercialization across Europe provides recurring revenue stream and market validation for proprietary surface technology
  • Fibrin-PTH Phase 2 trial represents next major value inflection; combines pharmaceutical and biologic modalities as first-of-kind approach
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Sep 2022Completed CHF 6.0 million private placement to extend runway into Q2 2024 and support Phase 2 Fibrin-PTH trial
  • 2021-2022Expanded MagnetOs distribution agreements across Northern Europe including Netherlands, Switzerland, Austria, and Finland
  • +1 moreTrack every material event for Kuros Biosciences AG as it happens. Explore monitoring →
Get alerted when Kuros Biosciences AG has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

INFUSE Bone GraftRecombinant human bone morphogenetic protein bone graft→Synthetic Bone GraftsOrthobiologic solutions for spinal fusion→3D Spinal Fusion SolutionsSpecialized spine care devices and biologics→

Compare Kuros Biosciences AG with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Kuros Biosciences AG operates in Orthobiologics/Medical Devices - Spinal Fusion. See how the rest of the sector scores on the Cyborg framework.

Browse Orthobiologics/Medical Devices - Spinal Fusion research →
NEW · MCP server

Ask your AI assistant about Kuros Biosciences AG

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Kuros Biosciences AG and its top competitor on Cyborg Score”
“What did Kuros Biosciences AG do this quarter?”
“Is Kuros Biosciences AG a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Kuros Biosciences AG do?+
Kuros Biosciences is a Swiss biotech company developing innovative orthobiologic products focused on spinal fusion and bone regeneration. The company's lead commercial product, MagnetOs, is a synthetic bone graft with...
What is Kuros Biosciences AG's Cyborg Score?+
Kuros Biosciences AG has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Kuros Biosciences AG's main competitors?+
Named competitors include INFUSE Bone Graft, Synthetic Bone Grafts, 3D Spinal Fusion Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full Kuros Biosciences AG research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Kuros Biosciences AG research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Kuros Biosciences AG over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Orthobiologics research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Bonesupport Holding AB